** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39
** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34
** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption
** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co
** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。